Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials

Authors

  • Sidsel J. Juul a Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
  • Sára Rossetti b Department of Haematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
  • Michal Kicinski c EORTC Headquarters, Brussels, Belgium
  • Marleen A. E. van der Kaaij d Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands
  • Francesco Giusti e EORTC Headquarters, Brussels, Belgium (Present affiliation: Belgian Cancer Registry, Brussels, Belgium)
  • Paul Meijnders f Department of Radiation Oncology, Iridium Network, University of Antwerp, Antwerpen, Belgium
  • Berthe M. P. Aleman g Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
  • John M. M. Raemaekers h Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
  • Hanneke C. Kluin-Nelemans i Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
  • Michele Spina j Division of Medical Oncology and Immunerelated tumors, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy
  • Christophe Fermé k Department of Hematology, Gustave Roussy, Villejuif, France
  • Loïc Renaud l AP-HP, Hôpital Saint-Louis, Hemato-oncologie, DMU DHI; Université de Paris, Paris, France
  • Olivier Casasnovas m Department of Hematology, CHU Dijon-Bourgogne, Dijon, France
  • Aspasia Stamatoullas n Department of Hematology, Centre Henri Becquerel, Rouen, France
  • Marc André o Department of Hematology, CHU UCL NAMUR, Yvoir, Belgium
  • Fabien Le Bras p Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor, Créteil, France
  • Wouter J. Plattel i Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
  • Michel Henry-Amar q Centre de Traitement des Données du Cancéropôle Nord-Ouest, Centre François Baclesse, Caen, France
  • Martin Hutchings b Department of Haematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
  • Maja V. Maraldo a Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

DOI:

https://doi.org/10.1080/0284186X.2023.2195561

Keywords:

Hodgkin lymphoma, survivorship, work, education, employment

Abstract

Background

Disease-specific studies on the impact of Hodgkin lymphoma (HL) on education or work interruption and resumption are lacking.

Material and methods

In a cross-sectional study conducted among long-term HL survivors enrolled from 1964 to 2004 in nine randomised EORTC-LYSA trials, the interruption and resumption of education/work was investigated. Survivors alive 5–44 years after diagnosis who were studying or working at time of diagnosis were included (n = 1646). Patient and treatment characteristics were obtained from trial records. Education and work outcomes were collected using the Life Situation Questionnaire. Logistic regression was used to model education or work interruption; Cox regression was used to study resumption rates.

Results

Among survivors studying at time of diagnosis (n = 323), 52% (95% CI: 46–57%) interrupted their education; however, it was resumed within 24 months by 92% (95% CI: 87–96%). The probability of interruption decreased with time: the more recent the treatment era, the lower the risk (OR 0.70 per 10 years, 95% CI: 0.49–1.01). Treatment with radiotherapy (yes vs. no) was associated with a higher education resumption rate (HR 2.01, 95% CI 1.07–3.78) whereas age, sex, stage, radiotherapy field and chemotherapy were not.

Among survivors working at time of diagnosis (n = 1323), 77% (95% CI: 75–79%) interrupted their work. However, it was resumed within 24 months by 86% (95% CI: 84%-88%). Women were more likely to interrupt their work as compared to men (OR 1.90, 95% CI: 1.44–2.51) and, when interrupted, less likely to resume work (HR 0.70, 95% CI: 0.61–0.80). Survivors with a higher educational level were less likely to interrupt their work (OR 0.68 for university vs. no high school, 95% CI: 0.46–1.03); and when interrupted, more likely to resume work (HR 1.50 for university vs. no high school, 95% CI: 1.21–1.86). Increasing age was also associated with lower resumption rates (HR 0.62 for age ≥50 vs. 18–29 years, 95% CI: 0.41–0.94).

Conclusion

An interruption in education/work was common among long-term HL survivors. However, most of the survivors who interrupted their studies or work had resumed their activities within 24 months. In this study, no associations between survivors’ characteristics and failure to resume education were observed. Female sex, age ≥50 years, and a lower level of education were found to be associated with not resuming work after treatment for HL.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2023-07-03

How to Cite

Juul, S. J., Rossetti, S., Kicinski, M., van der Kaaij, M. A. E., Giusti, F., Meijnders, P., … Maraldo, M. V. (2023). Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials. Acta Oncologica, 62(7), 744–752. https://doi.org/10.1080/0284186X.2023.2195561